4,6-dichloro-N-[(1r,3r)-3-(5-methyl-1,3,4-oxadiazol-2-yl)cyclobutyl]-1,3,5-triazin-2-amine
Structure Info
- Chemspace ID
- CSSB20784378121 (In-Stock Building Blocks)
- IUPAC Name
- 4,6-dichloro-N-[(1r,3r)-3-(5-methyl-1,3,4-oxadiazol-2-yl)cyclobutyl]-1,3,5-triazin-2-amine
- Mol formula
- C10H10Cl2N6O
- Mol weight
- 301 Da
- Catalog Number(s)
- BBLS20784378121, BBV-1661330647, EN300-54997656, bbls20784378121
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.38
- Heavy atoms count
- 19
- Rotatable bond count
- 3
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.5
- Polar surface area (Å)
- 90
- Hydrogen bond acceptors count
- 6
- Hydrogen bond donors count
- 1
![Chemical structure of 4,6-dichloro-N-[(1r,3r)-3-(5-methyl-1,3,4-oxadiazol-2-yl)cyclobutyl]-1,3,5-triazin-2-amine (C10H10Cl2N6O) - CSSB20784378121](/st/structure/200/72f8ae8fbdb323e771ed44f8b550f986/CC1%253DNN%253DC%2528O1%2529%255BC%2540H%255D1C%255BC%2540%2540H%255D%2528C1%2529NC1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png "C10H10Cl2N6O")
- Zoom the structure
- CSSB20784378121
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 815.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 855.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 894.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 932.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 971.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,903.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 2,816.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 4,176.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 4,6-dichloro-N-[(1s,3s)-3-(5-methyl-1,3,4-oxadiazol-2-yl)cyclobutyl]-1,3,5-triazin-2-amine - CSSB20784888557](/st/structure/200/c893c5d9b539af765b1c7f4d42f349e5/CC1%253DNN%253DC%2528O1%2529%255BC%2540%2540H%255D1C%255BC%2540%2540H%255D%2528C1%2529NC1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
![Chemical structure of 4,6-dichloro-N-[1-(5-methyl-1,3,4-oxadiazol-2-yl)ethyl]-1,3,5-triazin-2-amine - CSSB21332073638](/st/structure/200/1f78153b7ff1149b98e96fe698030091/CC%2528NC1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1%2529C1%253DNN%253DC%2528C%2529O1.png)
![Chemical structure of 2,4-dichloro-6-[(2R,4r,6S)-2,6-dimethyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]-1,3,5-triazine - CSSB21332145957](/st/structure/200/07e33310dd31eb134325b92de6a0452f/C%255BC%2540H%255D1C%255BC%2540H%255D%2528C%255BC%2540%2540H%255D%2528C%2529N1C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1%2529C1%253DNN%253DC%2528C%2529O1.png)
![Chemical structure of 2,4-dichloro-6-[3-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]-1,3,5-triazine - CSSB21332129395](/st/structure/200/a42c32ddd6e8d593a75c194d356808f9/CC1%253DNN%253DC%2528O1%2529C1CCCN%2528C1%2529C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
![Chemical structure of 2,4-dichloro-6-[(2R,4R)-4-methoxy-2-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolidin-1-yl]-1,3,5-triazine - CSSB21332154311](/st/structure/200/660d5c7d9034bbc3f4bd4abc6bf0accc/CO%255BC%2540%2540H%255D1C%255BC%2540%2540H%255D%2528N%2528C1%2529C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1%2529C1%253DNN%253DC%2528C%2529O1.png)
![Chemical structure of 2,4-dichloro-6-[(2R,4S)-4-methoxy-2-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolidin-1-yl]-1,3,5-triazine - CSSB21332154310](/st/structure/200/011c816087b94a7b85db1f49b982c7c9/CO%255BC%2540H%255D1C%255BC%2540%2540H%255D%2528N%2528C1%2529C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1%2529C1%253DNN%253DC%2528C%2529O1.png)
![Chemical structure of 4,6-dichloro-N-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-1,3,5-triazin-2-amine - CSSB00024981523](/st/structure/200/34f60ecb4e3d6f976586ae823661571f/CC1%253DNN%253DC%2528CNC2%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN2%2529O1.png)
